Celia Economides | Vice President of Corporate and Public Affairs |
Richard Glickman | Chief Executive Officer |
Dennis Bourgeault | Chief Financial Officer |
Neil Solomons | Chief Medical Officer |
Michael Martin | Chief Operating Officer |
Ed Arce | HC Wainwright |
Joseph Schwartz | Leerink Partners |
Elemer Piros | Cantor Fitzgerald |
Doug Miehm | RBC Capital Markets |
David Martin | Bloom Burton |
Greetings. Welcome to Aurinia Pharmaceuticals Incorporated Q2 2018 Financial Results. At this time, all participants are in a listen only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded.